Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Huber

Showing results (11-20 of 752) with videos related to

Pageof 76
Sort By:
European Heart Journal|November 11, 2022
Platelet antiaggregation after an acute coronary syndrome: what about the elderly?Kurt Huber
Thrombosis and Haemostasis|December 8, 2010
The role of fibrinolysis in the era of primary percutaneous coronary interventionSigrun Halvorsen, Kurt Huber
European Heart Journal. Acute Cardiovascular Care|May 8, 2020
Covid-19: implications for prehospital, emergency and hospital care in patients with acute coronary syndromesKurt Huber, Patrick Goldstein
Wiener Klinische Wochenschrift|August 26, 2022
Reply to letter to the editors: The long-term prognosis of patients with takotsubo syndromeEdita Pogran, Kurt Huber
Thrombosis and Haemostasis|July 28, 2011
New insights into platelet function testing: from bench to bedsideDavid Varon, Kurt Huber
Lancet (London, England)|March 16, 2020
Antithrombotic treatment strategies after PCIThomas Gremmel, Kurt Huber
Journal of Clinical Lipidology|January 23, 2020
Response to: "Arrhythmia paradox in patients with familial hypercholesterolemia"Maximilian Tscharre, Kurt Huber
Thrombosis and Haemostasis|August 21, 2015
Platelets, inflammation and anti-inflammatory drugs in ACS and CADKarsten Schrör, Kurt Huber
Wiener Klinische Wochenschrift|November 7, 2008
[Lipid profiles and therapy status in the secondary prevention of high risk patients with cardiovascular disease and/or diabetes mellitus: the Austrian Hospital Screening Project (HSP)]Michael Roden, Kurt Huber,
Current Opinion in Critical Care|September 24, 2004
Inflammation and cardiovascular diseases: lessons that can be learned for the patient with cardiogenic shock in the intensive care unitAlexander Geppert, Kurt Huber
Pageof 76

Showing results (11-20 of 752) with videos related to

Sort By:
Pageof 76
European Heart Journal|November 11, 2022
Platelet antiaggregation after an acute coronary syndrome: what about the elderly?Kurt Huber
Thrombosis and Haemostasis|December 8, 2010
The role of fibrinolysis in the era of primary percutaneous coronary interventionSigrun Halvorsen, Kurt Huber
European Heart Journal. Acute Cardiovascular Care|May 8, 2020
Covid-19: implications for prehospital, emergency and hospital care in patients with acute coronary syndromesKurt Huber, Patrick Goldstein
Wiener Klinische Wochenschrift|August 26, 2022
Reply to letter to the editors: The long-term prognosis of patients with takotsubo syndromeEdita Pogran, Kurt Huber
Thrombosis and Haemostasis|July 28, 2011
New insights into platelet function testing: from bench to bedsideDavid Varon, Kurt Huber
Lancet (London, England)|March 16, 2020
Antithrombotic treatment strategies after PCIThomas Gremmel, Kurt Huber
Journal of Clinical Lipidology|January 23, 2020
Response to: "Arrhythmia paradox in patients with familial hypercholesterolemia"Maximilian Tscharre, Kurt Huber
Thrombosis and Haemostasis|August 21, 2015
Platelets, inflammation and anti-inflammatory drugs in ACS and CADKarsten Schrör, Kurt Huber
Wiener Klinische Wochenschrift|November 7, 2008
[Lipid profiles and therapy status in the secondary prevention of high risk patients with cardiovascular disease and/or diabetes mellitus: the Austrian Hospital Screening Project (HSP)]Michael Roden, Kurt Huber,
Current Opinion in Critical Care|September 24, 2004
Inflammation and cardiovascular diseases: lessons that can be learned for the patient with cardiogenic shock in the intensive care unitAlexander Geppert, Kurt Huber
Pageof 76